Type of Cancer
Leukemia
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2 Study of the Efficacy and Safety Of ACP-196 in Subjects with Relapsed/ Refractory CLL and Intolerant of Ibrutinib Therapy
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.